Published in Int J Radiat Oncol Biol Phys on February 03, 2010
Competing causes of death and medical comorbidities among patients with human papillomavirus-positive vs human papillomavirus-negative oropharyngeal carcinoma and impact on adherence to radiotherapy. JAMA Otolaryngol Head Neck Surg (2014) 0.86
Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. Rep Pract Oncol Radiother (2015) 0.83
Preoperative radiotherapy for rectal cancer: a comparative study of quality control adherence at two cancer hospitals in Spain and Poland. Radiol Oncol (2014) 0.78
Correlation of radiation treatment interruptions with psychiatric disease and performance status in head and neck cancer patients. Support Care Cancer (2013) 0.75
Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer. Strahlenther Onkol (2013) 0.75
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. J Natl Cancer Inst (2010) 4.04
Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood) (2013) 3.69
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol (2012) 2.72
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer (2006) 2.42
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice. Genet Med (2010) 2.40
Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst (2014) 2.30
Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Spec Pharm (2015) 2.15
Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw (2012) 2.13
Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol (2013) 2.11
Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy. Med Phys (2010) 1.99
Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. J Comp Eff Res (2012) 1.91
Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling study. Ann Intern Med (2014) 1.87
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Multi-modality mediastinal staging for lung cancer among medicare beneficiaries. J Thorac Oncol (2009) 1.76
Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology (2004) 1.71
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Med Decis Making (2013) 1.70
The effect of lung volume reduction surgery on chronic obstructive pulmonary disease exacerbations. Am J Respir Crit Care Med (2007) 1.68
Design, implementation, and first-year outcomes of a value-based drug formulary. J Manag Care Spec Pharm (2015) 1.67
The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics (2009) 1.56
Modulation of thermal pain-related brain activity with virtual reality: evidence from fMRI. Neuroreport (2004) 1.49
Arteriovenous fistula and pseudoaneurysm of the anterior spinal artery caused by an epidural needle in a 5-year-old patient. J Neurosurg Pediatr (2013) 1.46
Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care (2007) 1.38
Breast cancer in limited-resource countries: health care systems and public policy. Breast J (2006) 1.35
Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med (2012) 1.32
Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization. Med Care (2005) 1.31
Economic burden for informal caregivers of lung and colorectal cancer patients. Oncologist (2010) 1.30
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
Gene expression profiling and breast cancer care: what are the potential benefits and policy implications? Genet Med (2005) 1.27
Risk factors for statin-associated rhabdomyolysis. Pharmacoepidemiol Drug Saf (2007) 1.27
Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care (2010) 1.24
Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected]. Int J Radiat Oncol Biol Phys (2012) 1.23
A survey to determine the understanding of the conceptual basis and diagnostic tests used for brain death by neurosurgeons in Canada. Neurosurgery (2007) 1.21
End-of-life care in the intensive care unit: can we simultaneously increase quality and reduce costs? Am J Respir Crit Care Med (2012) 1.20
An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol (2011) 1.18
Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer. Urol Oncol (2009) 1.17
Measuring costs: administrative claims data, clinical trials, and beyond. Med Care (2002) 1.16
Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. Am J Med (2005) 1.16
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer. Value Health (2008) 1.16
Controversies and advances in non-steroidal anti-inflammatory drug (NSAID) analgesia in chronic pain management. Postgrad Med J (2011) 1.15
Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature. Neurosurg Focus (2012) 1.14
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD (2007) 1.12
Economic analyses of human genetics services: a systematic review. Genet Med (2005) 1.10
Does adherence make a difference? Results from a community-based aquatic exercise program. Nurs Res (2002) 1.10
Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study. J Am Pharm Assoc (2003) (2008) 1.10
Recent advances in opioid prescription for chronic non-cancer pain. Postgrad Med J (2011) 1.08
New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder. J Am Geriatr Soc (2012) 1.08
Alcohol screening scores and risk of hospitalizations for GI conditions in men. Alcohol Clin Exp Res (2007) 1.07
Comparative clinical and economic outcomes of treatments for refractory non-small cell lung cancer (NSCLC). Lung Cancer (2008) 1.06
Automated tracing of neurites from light microscopy stacks of images. Neuroinformatics (2011) 1.05
Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol (2005) 1.05
Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology (2014) 1.05
Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants. Pharmacoepidemiol Drug Saf (2005) 1.03
Health technology assessment in health-care decisions in the United States. Value Health (2009) 1.03
A multifaceted intervention in support of diabetes treatment guidelines: a cont trial. Diabetes Res Clin Pract (2002) 1.02
Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer. J Oncol Pract (2013) 1.01
Costs of pulmonary rehabilitation and predictors of adherence in the National Emphysema Treatment Trial. COPD (2008) 1.00
Alcohol screening scores predict risk of subsequent fractures. Subst Use Misuse (2009) 1.00
Is the use of benzodiazepines associated with incident disability? J Am Geriatr Soc (2002) 1.00
Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg (2006) 0.99
Trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg (2009) 0.99
Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. J Natl Cancer Inst (2013) 0.98
Stakeholder perspectives on a risk-benefit framework for genetic testing. Public Health Genomics (2010) 0.98
Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int (2011) 0.98
The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007). Contemp Clin Trials (2012) 0.97
Decompressive hemicraniectomy in children with severe ischemic stroke and life-threatening cerebral edema. J Child Neurol (2008) 0.96
Improving early cycle economic evaluation of diagnostic technologies. Expert Rev Pharmacoecon Outcomes Res (2014) 0.96
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol (2009) 0.95
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making (2005) 0.94
Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. J Oncol Pract (2013) 0.93
Cetuximab plus cisplatin, irinotecan, and thoracic radiotherapy as definitive treatment for locally advanced, unresectable esophageal cancer: a phase-II study of the SWOG (S0414). J Thorac Oncol (2012) 0.93
Economic analyses and clinical practice guidelines: why not a match made in heaven? J Gen Intern Med (2002) 0.93
Is distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer? J Rural Health (2011) 0.93
Pharmacoeconomic evaluations in the treatment of non-small cell lung cancer. Drugs (2008) 0.92
Costs and outcomes evaluation of patient navigation after abnormal cancer screening: evidence from the Patient Navigation Research Program. Cancer (2013) 0.92
Benzodiazepine use in older adults enrolled in a health maintenance organization. Am J Geriatr Psychiatry (2003) 0.92
Genetic services for familial cancer patients: a follow-up survey of National Cancer Institute Cancer Centers. J Clin Oncol (2005) 0.92
Increased risk of adenomas in individuals with a family history of colorectal cancer: results of a meta-analysis. Cancer Causes Control (2010) 0.92
Clinical use of medical devices in the 'Bermuda Triangle'. Health Aff (Millwood) (2004) 0.92
Pediatric spinal glioblastoma multiforme: current treatment strategies and possible predictors of survival. Childs Nerv Syst (2012) 0.92
Genetic testing and pharmacogenomics: issues for determining the impact to healthcare delivery and costs. Am J Manag Care (2004) 0.91
Pharmacist provision of language-appropriate education for Asian patients with asthma. J Am Pharm Assoc (2003) (2004) 0.91
Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. Int J Radiat Oncol Biol Phys (2004) 0.91
Pulsed radio frequency: a non-neurodestructive therapy in pain management. Curr Opin Support Palliat Care (2010) 0.90
Contribution of CYP3A5 to hepatic and renal ifosfamide N-dechloroethylation. Drug Metab Dispos (2005) 0.89
Preference values associated with stage III colon cancer and adjuvant chemotherapy. Qual Life Res (2010) 0.89
Will knowledge of gene-based colorectal cancer disease risk influence quality of life and screening behavior? Findings from a population-based study. Public Health Genomics (2009) 0.88
Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy. Epilepsia (2011) 0.88
Dermatopathia pigmentosa reticularis. Pediatr Dermatol (2007) 0.87
Headache, fever and back pain in a 16-year-old boy. Can J Infect Dis (2004) 0.86
Discontinuation of radiation treatment among medicaid-enrolled women with local and regional stage breast cancer. Breast J (2009) 0.86
The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma. Cancer (2005) 0.86
Completion of radiotherapy for local and regional head and neck cancer in medicare. Arch Otolaryngol Head Neck Surg (2009) 0.86
Systematic review of comparative effectiveness data for oncology orphan drugs. Am J Manag Care (2012) 0.86
Adverse events associated with bevacizumab and chemotherapy in older patients with metastatic colorectal cancer. Clin Colorectal Cancer (2012) 0.86